Townsend & Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Buy
14,821
+542
+4% +$52K 0.12% 63
2026
Q1
$1.38M Buy
14,279
+115
+0.8% +$13K 0.12% 62
2025
Q4
$1.58M Buy
14,164
+278
+2% +$30.2K 0.14% 61
2025
Q3
$1.66M Buy
13,886
+66
+0.5% +$8.19K 0.16% 59
2025
Q2
$1.81M Sell
13,820
-412
-3% -$55K 0.18% 58
2025
Q1
$1.97M Buy
14,232
+2,320
+19% +$354K 0.21% 53
2024
Q4
$1.91M Sell
11,912
-43
-0.4% -$7.03K 0.2% 54
2024
Q3
$1.9M Buy
11,955
+464
+4% +$68.8K 0.2% 54
2024
Q2
$1.55M Sell
11,491
-161
-1% -$22.4K 0.17% 56
2024
Q1
$1.7M Sell
11,652
-158
-1% -$23.6K 0.2% 54
2023
Q4
$1.65M Buy
11,810
+192
+2% +$25.6K 0.21% 55
2023
Q3
$1.37M Buy
11,618
+6,379
+122% +$969K 0.29% 56
2023
Q2
$802K Buy
5,239
+634
+14% +$102K 0.21% 81
2023
Q1
$763K Buy
4,605
+1,696
+58% +$254K 0.31% 79
2022
Q4
$445K Buy
+2,909
New +$413K 0.22% 77
2018
Q2
Sell
-37
Closed -$5K 163
2018
Q1
$5K Sell
37
-14,961
-100% -$2.01M ﹤0.01% 142
2017
Q4
$2.23M Buy
+14,998
New +$2.04M 1.9% 5

Other funds holding CLX

Townsend & Associates's CLX Position: Q2 2026 in Review

Townsend & Associates increased its Clorox (CLX) stake by 3.8% in Q2 2026, buying an estimated $52K and bringing the position to 14,821 shares worth $1.43M. The position accounts for 0.12% of the portfolio, ranked #63.

Townsend & Associates first reported a position in CLX in Q4 2017 and has held it in 17 quarters since. The position peaked at $2.23M in Q4 2017. 434 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Townsend & Associates held 14,821 shares of Clorox worth $1.43M as of Q2 2026.
  • Townsend & Associates bought 542 Clorox shares in Q2 2026, an estimated $52K.
  • Clorox made up 0.12% of Townsend & Associates's portfolio in Q2 2026, its #63 holding.
  • Townsend & Associates first reported a position in Clorox in Q4 2017 and has held it in 17 quarters since.
  • Townsend & Associates's Clorox position peaked at $2.23M in Q4 2017.
  • 434 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.